Search Results 521-530 of 11908 for scad

  1. Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma - Mayo Clinic

    About this study. This phase II trial studies how well glembatumumab vedotin works in treating patients with middle layer of the wall of the eye (uveal) ...

  2. Select a county MN, Catchment County, Waseca. Waseca County Population Total: 18,612. Catchment County. Catchment County (MCHS). Selected County.

  3. Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian) - Mayo Clinic

    Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian) · Overview.

  4. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

    A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to ...

  5. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  6. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...

  7. A Study of a Virtual Reality Module in Adolescents to Retrain their Brain to Make Healthier Choices - Mayo Clinic

    To examine the effect of a weight management intervention utilizing the virtual reality module (VRM) on body weight, BMI and waist circumference outcomes in ...

  8. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study of What is Different in People with Alopecia Areata that Makes T cells Attack Hair Follicles - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Study to Evaluate and Compare Effectiveness Among New Measuring Methods to Find Minimal Residual Disease Following Stem Cell Transplant for Multiple Myeloma - Mayo Clinic

    The purpose of this study is to evaluate and compare the effectiveness of new methods of measuring more accurately for minimal residual disease following bone ...